KORU Medical Systems, Inc. Common Stock (DE) financials
$3.01−1.80%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Fiscal year | FY25 Dec 31 | FY24 Dec 31 | FY23 Dec 31 | FY22 Dec 31 | FY21 Dec 31 | FY20 Dec 31 | FY19 Dec 31 |
|---|---|---|---|---|---|---|---|
| Revenue | $41.1M | $33.6M | $28.5M | $27.9M | $23.5M | $24.2M | $23.2M |
| Gross profit | $25.6M | $21.3M | $16.7M | $15.4M | $13.8M | $14.9M | $14.9M |
| Gross margin | 62.3% | 63.4% | 58.6% | 55.1% | 58.6% | 61.8% | 64.1% |
| Operating income | -$3.0M | -$6.4M | -$10.3M | -$10.8M | -$7.0M | -$1.3M | $585.7K |
| Net income | -$2.6M | -$6.1M | -$13.7M | -$8.7M | -$4.6M | -$1.2M | $564.3K |
| Net margin | −6.4% | −18.0% | −48.2% | −31.0% | −19.4% | −5.0% | 2.4% |
| Diluted EPS | $-0.06 | $-0.13 | $-0.30 | $-0.19 | $-0.10 | $-0.03 | $0.01 |
| EBITDA | -$2.2M | -$5.6M | -$9.4M | -$10.2M | -$6.6M | $1.6M | $4.3M |
| Operating cash flow | $462.4K | -$319.7K | -$4.9M | -$5.4M | -$4.3M | -$743.3K | $320.6K |
| Free cash flow | -$470.1K | -$1.6M | -$5.7M | -$8.2M | -$4.7M | -$1.7M | $119.4K |
| Diluted shares | 46.2M | 45.8M | 45.6M | 45.0M | 44.4M | 41.9M | 39.1M |
Balance sheet
| Period end | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $8.9M | $9.6M | $11.5M | $17.4M | $25.3M | $27.3M |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 | — | — |
| Total debt | $203.6K | $589.4K | $740.5K | $925.9K | $508.6K | $2.6K |
| Total assets | $28.2M | $27.2M | $28.5M | $42.3M | $41.3M | $39.9M |
| Total liabilities | $11.2M | $10.4M | $8.1M | $11.0M | $4.8M | $3.8M |
| Shareholders' equity | $17.0M | $16.8M | $20.4M | $31.3M | $36.5M | $36.2M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology